{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:56:07Z","timestamp":1789480567128,"version":"build-2803163510"},"reference-count":72,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jaad.2023.08.084","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T02:50:16Z","timestamp":1694659816000},"page":"13-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome: Part II. Diagnosis and management"],"prefix":"10.1016","volume":"91","author":[{"given":"Simo","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6399-2719","authenticated-orcid":false,"given":"Jason B.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.jaad.2023.08.084_bib1","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","article-title":"Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia","volume":"323","author":"Anhalt","year":"1990","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jaad.2023.08.084_bib2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/archderm.1993.01680280071014","article-title":"Paraneoplastic pemphigus is a distinct neoplasia-induced autoimmune disease","volume":"129","author":"Camisa","year":"1993","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2023.08.084_bib3","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/cup.14004","article-title":"Paraneoplastic pemphigus: revised diagnostic criteria based on literature analysis","volume":"48","author":"Svoboda","year":"2021","journal-title":"J Cutan Pathol"},{"issue":"8","key":"10.1016\/j.jaad.2023.08.084_bib4","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/archderm.1992.01680180085011","article-title":"Histologic features of paraneoplastic pemphigus","volume":"128","author":"Horn","year":"1992","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.08.084_bib5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1067\/mjd.2000.107488","article-title":"Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus","volume":"43","author":"Joly","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2023.08.084_bib6","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/bjd.14162","article-title":"Clinical and immunological findings in 104 cases of paraneoplastic pemphigus","volume":"173","author":"Ohzono","year":"2015","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.08.084_bib7","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1046\/j.1365-2133.1999.02737.x","article-title":"Paraneoplastic pemphigus presenting as erosive lichen planus","volume":"140","author":"Passeron","year":"1999","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2023.08.084_bib8","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/1346-8138.13329","article-title":"Erosive oral lichen planus as a sign of paraneoplastic pemphigus","volume":"43","author":"Wang","year":"2016","journal-title":"J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.08.084_bib9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4103\/ijd.IJD_196_17","article-title":"Advanced diagnostic techniques in autoimmune bullous diseases","volume":"62","author":"Jindal","year":"2017","journal-title":"Ind J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.08.084_bib10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-0560.2008.00993.x","article-title":"Paraneoplastic pemphigus with negative direct immunofluorescence in epidermis or mucosa but positive findings in adnexal structures","volume":"36","author":"Barnadas","year":"2009","journal-title":"J Cutan Pathol"},{"issue":"10","key":"10.1016\/j.jaad.2023.08.084_bib11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/archderm.1982.01650220027005","article-title":"An unusual type of pemphigus: combining features of lupus erythematosus","volume":"118","author":"Senear","year":"1982","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.08.084_bib12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0190-9622(95)90066-7","article-title":"Accuracy of indirect immunofluorescence testing in the diagnosis of paraneoplastic pemphigus","volume":"32","author":"Helou","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2023.08.084_bib15","first-page":"1103","article-title":"Evaluation of a newly available ELISA for envoplakin autoantibodies for the diagnosis of paraneoplastic pemphigus","volume":"14","author":"Powell","year":"2015","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.08.084_bib16","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1002\/ski2.142","article-title":"Indirect immunofluorescence on rat bladder epithelium in patients with pemphigus vulgaris with an extended follow-up","volume":"2","author":"Samadi","year":"2022","journal-title":"Skin Health Dis"},{"issue":"4","key":"10.1016\/j.jaad.2023.08.084_bib17","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3390\/ijms19040974","article-title":"Mammalian plakins, giant cytolinkers: versatile biological functions and roles in cancer","volume":"19","author":"Hu","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaad.2023.08.084_bib18","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3389\/fimmu.2019.01259","article-title":"Paraneoplastic pemphigus: paraneoplastic autoimmune disease of the skin and mucosa","volume":"10","author":"Kim","year":"2019","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2023.08.084_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5980\/jpnjurol.108.87","article-title":"Expression of plakin family in urothelial carcinoma of the upper urinary tract","volume":"108","author":"Hasegawa","year":"2017","journal-title":"Jpn J Urol"},{"issue":"1","key":"10.1016\/j.jaad.2023.08.084_bib20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/PAT.0000000000000196","article-title":"Comparative study of five serological assays for the diagnosis of paraneoplastic pemphigus","volume":"47","author":"Kelly","year":"2015","journal-title":"Pathology"},{"issue":"1","key":"10.1016\/j.jaad.2023.08.084_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/15665240113136660079","article-title":"Molecular diagnosis\u00a0in\u00a0autoimmune skin blistering conditions","volume":"14","author":"Otten","year":"2014","journal-title":"Curr Mol Med"},{"issue":"5","key":"10.1016\/j.jaad.2023.08.084_bib22","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/bjd.12479","article-title":"Laboratory diagnosis of paraneoplastic pemphigus","volume":"169","author":"Poot","year":"2013","journal-title":"Br J Dermatol"},{"issue":"1-2","key":"10.1016\/j.jaad.2023.08.084_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cca.2009.08.022","article-title":"Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus","volume":"410","author":"Probst","year":"2009","journal-title":"Clin Chim Acta"},{"issue":"10","key":"10.1016\/j.jaad.2023.08.084_bib24","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00403-008-0901-y","article-title":"Detection of anti-envoplakin and anti-periplakin autoantibodies by ELISA in patients with paraneoplastic pemphigus","volume":"301","author":"Huang","year":"2009","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"10.1016\/j.jaad.2023.08.084_bib25","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1172\/JCI3647","article-title":"Antibodies against\u00a0desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus\u00a0and cause acantholysis in\u00a0vivo in neonatal mice","volume":"102","author":"Amagai","year":"1998","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.jaad.2023.08.084_bib26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1067\/mjd.2001.112222","article-title":"Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus","volume":"44","author":"Ohyama","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2023.08.084_bib27","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.1992.03480110076037","article-title":"Paraneoplastic pemphigus with autoantibody deposition in bronchial epithelium after autologous bone marrow transplantation","volume":"267","author":"Fullerton","year":"1992","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jaad.2023.08.084_bib28","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1046\/j.1523-1747.1998.00449.x","article-title":"Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex","volume":"111","author":"Kiyokawa","year":"1998","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.08.084_bib29","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1523-1747.2001.01263.x","article-title":"Paraneoplastic pemphigus sera react strongly with multiple epitopes on the various regions of envoplakin and periplakin, except for the c-terminal homologous domain of periplakin","volume":"116","author":"Nagata","year":"2001","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2023.08.084_bib30","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2013.65","article-title":"Anti-\u03b1-2-macroglobulin-like-1 autoantibodies are detected frequently and may be pathogenic in paraneoplastic pemphigus","volume":"133","author":"Numata","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2023.08.084_bib31","article-title":"Paraneoplastic pemphigus: an indication for treatment in chronic lymphocytic leukemia","volume":"12","author":"Onukogu","year":"2020","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.jaad.2023.08.084_bib32","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12876-019-1008-y","article-title":"Paraneoplastic pemphigus and myasthenia gravis as the first manifestations of a rare case of pancreatic follicular dendritic cell sarcoma: CT findings and review of literature","volume":"19","author":"Lu","year":"2019","journal-title":"BMC Gastroenterol"},{"issue":"8","key":"10.1016\/j.jaad.2023.08.084_bib33","article-title":"Paraneoplastic pemphigus in a patient with carcinosarcoma of the uterus","volume":"12","author":"Giebel","year":"2010","journal-title":"Med Forum"},{"issue":"4","key":"10.1016\/j.jaad.2023.08.084_bib34","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/bjd.13525","article-title":"Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis","volume":"172","author":"Wang","year":"2015","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2023.08.084_bib35","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/08916930600972099","article-title":"Paraneoplastic autoimmune multiorgan syndrome: review of the literature and support for a cytotoxic role in pathogenesis","volume":"39","author":"Billet","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaad.2023.08.084_bib36","series-title":"StatPearls","article-title":"Paraneoplastic pemphigus","author":"Kappius","year":"2022"},{"issue":"4","key":"10.1016\/j.jaad.2023.08.084_bib37","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1046\/j.1365-2133.2002.04992.x","article-title":"Paraneoplastic pemphigus in children and adolescents","volume":"147","author":"Mimouni","year":"2002","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.08.084_bib38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1440-1843.2008.01397.x","article-title":"Constrictive bronchiolitis associated with paraneoplastic autoimmune multi-organ syndrome","volume":"14","author":"Maldonado","year":"2009","journal-title":"Respirology"},{"issue":"2","key":"10.1016\/j.jaad.2023.08.084_bib39","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1378\/chest.117.2.603","article-title":"Paraneoplastic pemphigus associated with bronchiolitis obliterans","volume":"117","author":"Takahashi","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.jaad.2023.08.084_bib40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/CCID.S100802","article-title":"Paraneoplastic pemphigus: a short review","volume":"9","author":"Wieczorek","year":"2016","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.08.084_bib41","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s12032-009-9304-y","article-title":"A critical role of surgery in the treatment for paraneoplastic pemphigus caused by localized Castleman's disease","volume":"27","author":"Fang","year":"2010","journal-title":"Med Oncol"},{"key":"10.1016\/j.jaad.2023.08.084_bib42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1477-7819-6-83","article-title":"Paraneoplastic pemphigus regression after thymoma resection","volume":"6","author":"Barbetakis","year":"2008","journal-title":"World J Surg Oncol"},{"issue":"6","key":"10.1016\/j.jaad.2023.08.084_bib43","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1365-2133.2003.05659.x","article-title":"Paraneoplastic pemphigus in association with Castleman's disease","volume":"149","author":"Nikolskaia","year":"2003","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2023.08.084_bib44","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/archderm.134.6.706","article-title":"Immunoapheresis in paraneoplastic pemphigus","volume":"134","author":"Schoen","year":"1998","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2023.08.084_bib45","article-title":"Radiotherapy-associated paraneoplastic pemphigus and its complications in a patient with nasopharyngeal carcinoma","volume":"7","author":"Khair","year":"2020","journal-title":"Eur J Case Rep Intern Med"},{"issue":"4","key":"10.1016\/j.jaad.2023.08.084_bib46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1440-0960.1995.tb00976.x","article-title":"Paraneoplastic pemphigus triggered by radiotherapy","volume":"36","author":"Lee","year":"1995","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2023.08.084_bib47","doi-asserted-by":"crossref","first-page":"84","DOI":"10.26502\/jcsct.5079010","article-title":"Paraneoplastic pemphigus in A patient with chronic lymphocytic leukemia: a case report","volume":"2","author":"Kus","year":"2018","journal-title":"J Cancer Sci Clin Ther"},{"issue":"7","key":"10.1016\/j.jaad.2023.08.084_bib48","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/oxfordjournals.annonc.a059294","article-title":"Lethal paraneoplastic pemphigus following treatment of chronic lymphocytic leukaemia with fludarabine","volume":"6","author":"Bazarbachi","year":"1995","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.jaad.2023.08.084_bib49","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.det.2011.06.016","article-title":"Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome)","volume":"29","author":"Frew","year":"2011","journal-title":"Dermatol Clin"},{"issue":"2","key":"10.1016\/j.jaad.2023.08.084_bib50","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-4632.2009.03995.x","article-title":"Paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome","volume":"48","author":"Sehgal","year":"2009","journal-title":"Int J Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2023.08.084_bib51","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archdermatol.2012.1830","article-title":"Prognostic factors of paraneoplastic pemphigus","volume":"148","author":"Leger","year":"2012","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.08.084_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.23937\/2469-5750\/1510046","article-title":"Paraneoplastic pemphigus","volume":"3","author":"Zhong-Shuai","year":"2017","journal-title":"J Dermatol Res and Ther"},{"issue":"3","key":"10.1016\/j.jaad.2023.08.084_bib53","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1586\/1744666X.4.3.351","article-title":"Rationale and efficacy for the use of rituximab in paraneoplastic pemphigus","volume":"4","author":"Vezzoli","year":"2008","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2023.08.084_bib54","first-page":"105","article-title":"Paraneoplastic pemphigus in two patients with B-cell non-Hodgkin's lymphoma: significant responses to cyclophosphamide and prednisolone","volume":"63","author":"Hertzberg","year":"2000","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.jaad.2023.08.084_bib55","first-page":"551","article-title":"Paraneoplastic pemphigus treated with dexamethasone\/ cyclophosphamide pulse therapy","volume":"8","author":"Becker","year":"1998","journal-title":"Eur J Dermatol"},{"issue":"5 Pt 1","key":"10.1016\/j.jaad.2023.08.084_bib56","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0190-9622(99)70157-X","article-title":"Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease","volume":"40","author":"Nousari","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.08.084_bib57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00128071-200708020-00004","article-title":"Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris","volume":"8","author":"Olszewska","year":"2007","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.08.084_bib58","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1046\/j.1365-2133.2000.03365.x","article-title":"Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus","volume":"142","author":"Williams","year":"2000","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.08.084_bib59","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0190-9622(92)70220-A","article-title":"Paraneoplastic pemphigus: a report of three cases including one long-term survivor","volume":"27","author":"Camisa","year":"1992","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2023.08.084_bib60","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1365-4362.1997.tb01154.x","article-title":"Retroperitoneal round-cell liposarcoma associated with paraneoplastic pemphigus presenting as lichen planus pemphigoides-like eruption","volume":"36","author":"Krunic","year":"1997","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.08.084_bib61","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/1346-8138.13160","article-title":"Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and intractable mucosal erosions: treatment with cyclosporin in addition to steroid, rituximab and intravenous immunoglobulin","volume":"43","author":"Namba","year":"2016","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.08.084_bib62","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000070972","article-title":"Successful treatment of B cell chronic lymphocytic leukemia-associated severe paraneoplastic pemphigus with cyclosporin A","volume":"109","author":"Gergely","year":"2003","journal-title":"Acta Haematol"},{"issue":"2","key":"10.1016\/j.jaad.2023.08.084_bib63","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/jid.2008.192","article-title":"B-cell-directed therapy for inflammatory skin diseases","volume":"129","author":"Nagel","year":"2009","journal-title":"J Invest Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2023.08.084_bib64","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1346-8138.2010.01192.x","article-title":"Paraneoplastic pemphigus associated with corneal perforation and cutaneous alternariosis: a case report and review of cases treated with rituximab","volume":"38","author":"Anan","year":"2011","journal-title":"J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.08.084_bib65","first-page":"269","article-title":"Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus","volume":"137","author":"Borradori","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2023.08.084_bib66","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1749-6632.2009.04744.x","article-title":"Rituximab in severe pemphigus","volume":"1173","author":"Schmidt","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.jaad.2023.08.084_bib67","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-0609.2004.00280.x","article-title":"Alemtuzumab-induced remission of both severe paraneoplastic pemphigus and leukaemic bone marrow infiltration in a case of treatment-resistant B-cell chronic lymphocytic leukaemia","volume":"73","author":"Hohwy","year":"2004","journal-title":"Eur J Haematol"},{"issue":"2","key":"10.1016\/j.jaad.2023.08.084_bib68","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bjd.12324","article-title":"Alemtuzumab is effective against severe chronic lymphocytic\u00a0leukaemia-associated paraneoplastic pemphigus","volume":"169","author":"Bech","year":"2013","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.08.084_bib69","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2008.09.052","article-title":"A randomized double-blind trial of intravenous immunoglobulin for pemphigus","volume":"60","author":"Amagai","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2023.08.084_bib70","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1365-4632.2007.03225.x","article-title":"Paraneoplastic pemphigus in association with B-cell lymphocytic leukemia and hepatitis C: favorable response to intravenous immunoglobulins and prednisolone","volume":"46","author":"Nanda","year":"2007","journal-title":"Int J Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2023.08.084_bib71","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1080\/10428190410001733781","article-title":"Follicular non-Hodgkin's lymphoma with refractory paraneoplastic pemphigus: case report with review of novel treatment modalities","volume":"45","author":"Rossum","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.jaad.2023.08.084_bib72","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2133.1996.tb06349.x","article-title":"Paraneoplastic pemphigus: potential therapeutic effect of plasmapheresis","volume":"134","author":"Izaki","year":"1996","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.08.084_bib73","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/scd.12093","article-title":"The importance of multidisciplinary healthcare for paraneoplastic pemphigus","volume":"35","author":"Al Zamel","year":"2015","journal-title":"Spec Care Dentist"},{"issue":"4","key":"10.1016\/j.jaad.2023.08.084_bib74","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1046\/j.1365-2133.2003.05260.x","article-title":"Topical tacrolimus (FK506) for relapsing erosive stomatitis in paraneoplastic pemphigus","volume":"148","author":"Vecchietti","year":"2003","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962223026853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962223026853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T06:37:14Z","timestamp":1722321434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962223026853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0190962223026853"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2023.08.084","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome: Part II. Diagnosis and management","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2023.08.084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2023.08.020","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}